&more > CPhI and P-MEC India

CPhI and P-MEC India

India Report Expected to Offer Insights into Booming Market

India’s pharmaceutical market is forecast to become the sixth largest in the world by 2020 with profits reaching $55 billion, according to the India Brand Equity Foundation. In particular, generics are a large portion of this market. Currently representing 72 percent of India’s pharma revenues, the demand is largely a direct result of countries around the world seeking to reduce healthcare costs. As the newly elected Indian government enacts healthcare policy reforms in an effort to increase their citizen’s access to healthcare, the demand for generics is anticipated to rise.

Generics, however, are only one indicator of the growth of the Indian pharma industry. Over the last 7-years exports—including APIs, FDFs and biopharmaceuticals—grew at a CAGR of 15.2 percent from 2006 to 2013, representing a more than 100 percent increase. Overall growth is expected to continue throughout the Indian market at a CAGR of 13 percent, double the global average.

In collaboration with CPhI, Global Business Reports (GBR) has launched a comprehensive study on this dynamic market, exploring a number of issues that shape India’s pharmaceutical industry. In developing the report, researchers will conduct 50 exclusive face-to-face interviews with both private and public sector thought leaders. A sample of topics includes:

• Discussion and forecast for the evolving regulatory environment
• Growth potential in the biopharmaceutical and biotechnology markets
• Multiple methods for generating value-added R&D
• Foreign direct investment, M&A, and global alliances
• International expansion of Indian pharma companies

Once completed, the Pharma Insights Report will be the single most comprehensive intelligence report on the Indian pharmaceutical market, offering foresight and acumen on future growth opportunities. The report will be released in December at CPhI India.

Taking place from the 2nd to 4th of December in Mumbai, CPhI and P-MEC India connect visitors with suppliers of high-quality ingredients, pharmaceutical equipment and machinery. Alongside outsourced and biopharmaceutical services available to the Indian market through its exhibition and co-located events, ICSE and BioPh. This year, more than 28,000 visitors and 900 exhibitors representing 95 countries are expected to attend. CPhI India and P-MEC India offer the opportunity to connect with global buyers and suppliers, network with industry leaders, and take part in informative technical seminars. Together they provide the best and most efficient platform for entering into or growing in the Indian pharma market. Register online for free and guarantee your exclusive Indian Pharma industry report: http://bit.ly/1sHr4mV